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Available online 27 October 2016AbstractAim: To determine the incidence of acute kidney injury (AKI) based on Kidney Disease Improving Global Outcome (KDIGO) criteria in patients
with severe traumatic brain injury and to study AKI in relation to risk factors and outcomes.
Method: This trial was a descriptive analytic study on 83 patients with severe traumatic brain injury admitted to Poursina Hospital (Rasht, Iran).
The incidence of AKI was determined based on KDIGO criteria over a 12-month period. The correlation of mortality rates, multi-organ failure
(MOF), and neurologic outcome to AKI were studied.
Results: Of 83 eligible patients who entered the study, 25.3% (N¼ 21) developed AKI based on KDIGO criteria. Glasgow Outcome Scale on
admission was the only risk factor significantly associated with the incidence of AKI ( p¼ 0.001). Mortality rates (62% vs. 22.6%, p¼ 0.002)
and the occurrence of MOF were significantly higher in patients who developed AKI (23.8% vs. 0% MOF based on Sequential Organ Failure
Assessment, p< 0.0001; 19% vs. 0% MOF based on Multiple Organ Dysfunction score, p< 0.0001). Poor neurologic outcome was observed in
95% and 92% of patients with and without AKI, respectively ( p¼ 0.674).
Conclusion: The incidence of AKI among patients with severe traumatic brain injury is striking. The association of Glasgow Outcome Scale with
AKI helps to identify patients at a higher risk of developing AKI. Significant rates of mortality and MOF among patients with severe traumatic
brain injury and AKI, necessitates consideration of renoprotective measures from the early days of hospital admission.
Copyright © 2016, Taiwan Society of Emergency Medicine. Published by Elsevier Taiwan LLC. This is an open access article under the CC BY-
NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Traumatic brain injury (TBI) is among the leading causes
of mortality and morbidity worldwide. Primary and secondary
injuries to the brain could lead to hypoperfusion and ischemic
insult to non-neurologic organs.
Acute kidney injury (AKI) develops as a result of brain
insult or as a consequence of secondary inflammatory or septic
reactions. Using drugs with nephrotoxic side effects, such as* Corresponding author. 7426 Key Coloney Ave, apt 2226, FI 32792, USA
E-mail address: dr.ramtinfar@yahoo.com (S. Ramtinfar).
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ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).mannitol for the management of intracranial pressure, may
lead to complications like rhabdomyolysis due to trauma
which might play a considerable role in kidney injury and
should be taken into account.1
Several scoring systems are available to use in an intensive
care unit (ICU) setting, predicting mortality based on organ
failure. Sequential Organ Failure Assessment (SOFA) and
Multiple Organ Dysfunction (MOD) scoring systems are
implicated in the ICU for assessment of multi-organ failure
(MOF). Both systems consist of six components evaluating
renal, respiratory, coagulation, neurologic, cardiovascular, and
hepatic systems. Based on creatinine levels, scores of renal
component range from 0 to 4. Scores of 1 and 2 classify theby Elsevier Taiwan LLC. This is an open access article under the CC BY-NC-
Table 1
Definition of acute kidney injury (AKI) based on Kidney Disease Improving
Global Outcome (KDIGO) panel.
KDIGO defines AKI as any of the following:
Increase in serum creatinine by 0.3 mg/dL within 48 h or
Increase in serum creatinine to 1.5-times baseline within the last 7 d or
Urine output< 0.5 mL/kg/h for 6 h
Table 2
Basic characteristic features of the study population.
Age (y) 33± 18
Sex (M/F) 78/5
GCS on admission 5.9± 1.7
GOS on admission 2.4± 1.1
MAP on admission (mmHg) 93.2± 11.1
APACHE II 14.1± 3.8
SOFA score on 1st d of admission 5.5± 1.6
MODS score on 1st d of admission 5.4± 1.6
Maximum SOFA score during hospital stay (d) 8.4± 2.4
Maximum MODS score during hospital stay (d) 8± 2.1
Incidence of AKI 25.30% (n¼ 21)
Mortality 27.7% (n¼ 23)
Poor neurologic outcome (GOS 3) 79.5% (n¼ 66)
AKI¼ acute kidney injury; APACHE II¼Acute Physiology and Chronic
Health Evaluation; F¼ female; GCS¼Glasgow Coma Score;
GOS¼Glasgow Outcome Scale; M¼male; MAP¼mean arterial pressure;
MODS¼Multiple Organ Dysfunction Score; SOFA¼ Sequential Organ
Failure Assessment.
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dicators of renal failure. The threshold of creatinine which
classifies an insult into dysfunction or failure differs between
two scoring systems.2,3
Many systems have been developed for diagnosing and
staging AKI in ICU patients. Acute Kidney Injury Network
(AKIN), Risk, Injury, and Failure, and Loss, and End-stage
Kidney Disease (RIFLE), and Kidney Disease Improving
Global Outcome (KDIGO) are panels with different criteria.
AKIN criteria evaluates renal function based on serum creat-
inine or urine output during 48 hours.4,5 RIFLE criteria ob-
serves the creatinine level and glomerular filtration rate and
urine output over a span of 7 days.6 KDIGO criteria, which
was formed in 2012, monitors alterations in kidney function
similar to AKIN criteria but within 7 days, similar to that of
RIFLE criteria; thus including both previously designed
systems.7
Although limited studies have been performed, the inci-
dence of AKI among patients with severe TBI has been re-
ported as a variable range with regard to different definitions
of AKI.8,9 Studies of non-neurologic organ failure in patients
with TBI reported an incidence of <2% of AKI using SOFA
and MOD scoring systems.3,10e12 Based on different criteria,
AKI is estimated to have an incidence of 1.5e23% in a neu-
rotrauma setting8,10,13,14 and contributes to higher rates of
mortality and morbidity8,15 and poor neurologic outcome.6
The aim of this study was to define the incidence of AKI
based on KDIGO criteria in patients with severe head trauma,
and to evaluate AKI in association with risk factors and out-
comes of mortality, neurologic deterioration, and MOF.
2. Materials and methods
The present study was performed as a descriptive analytic
trial, after the approval of the Ethics Committee of Guilan
University of Medical Science (Rasht, Iran) and gathering
informed consent. All patients with severe TBI who were
admitted to the neurosurgery ICU of Poursina Hospital from
March 2013 to April 2014 were included. Enrolled in study
were patients with a TBI (due to traffic accidents) and one of
the following conditions: an initial resuscitation (systolic
blood pressure > 90 mmHg and arterial oxygen satura-
tion> 90%); Glasgow Coma Score (GCS) of 8 at ICU
admission; a postresuscitation GCS at presentation to the
Poursina Neurosurgery ICU of 8 in the absence of any type
of sedation and drug or alcohol overuse; indication for intra-
cranial pressure monitoring; or the presence of a clinical
herniation syndrome diagnosed by a neurosurgeon.16
Excluded from the study were patients with concomitant
trauma to the chest, abdomen, or pelvis, that resulted in vital
organ damage, patients with a previous history of vital organ
involvement, and patients with an unknown past medical
history. Acute Physiology and Chronic Health Evaluation
(APACHE) II score was calculated for all patients on the 1st
day of admission to ICU. During the period of the study,
SOFA and MOD scores were calculated daily for all patients
based on original guidelines. For any organ compartment,Score 0 was considered normal, Score 1 and 2 represented
organ dysfunction, Score 3 and 4 was demonstrative of organ
failure, and scores of 6 represented a state of MOF.2,3
A daily screening program based on KDIGO panel guide-
lines for AKI was applied for all patients during the study
period (Table 1). For statistical data analysis, SPSS version 21
(SPSS Inc., Chicago. IL, USA) was used. Incidence of AKI
defined by KDIGO criteria and frequency of MOF, based on
SOFA and MOD scores, were calculated. Fisher's exact test
and Pearson's Chi-square test were used to correlate the AKI
with risk factors and outcomes of mortality, MOF, and
neurologic outcome. In order to report the neurologic
outcome, Glasgow Outcome Scale (GOS) was dichotomized
into favorable (GOS: 4, 5) and unfavorable (GOS: 1, 2, 3).8
Multivariable linear regression analysis was used to detect
the relationship of risk factors with AKI. All tests were two-
sided and p< 0.05 was considered to be statistically
significant.
3. Results
Of all patients who were admitted to the ICU of Poursina
Hospital during the study period, 83 were eligible to enroll.
Most of the patients diagnosed with severe TBI were men
(93.9%) and were young (mean age: 33± 18 years). Mortality
rate was 27.7% (N¼ 23) and 79.5% of the study population
had shown a poor neurologic outcome (GOS¼ 1, 2, 3). The
incidence of AKI was reported as high as 25.3% (N¼ 21).
Basic characteristic features are shown in Table 2.
The only risk factor shown to be significantly related to
AKI was GOS on admission ( p¼ 0.001). Age, sex, GCS,
Table 3
Comparison of patients with and without acute kidney injury (AKI).
AKI No AKI p
Age (y) 36.3± 19.6 32.3± 17.6 0.398
Sex (M/F) 20/1 58/4 0.626
GCS on admission 5.8± 1.9 6 ± 1.7 0.738
GOS on admission 1.7± 1 2.6± 0.9 0.001
MAP on admission (mmHg) 93.7± 12 93± 10.9 0.798
APACHE II 14.9± 4.5 13.8± 3.6 0.317
SOFA score on 1st d of admission 5.6± 1.7 5.5± 1.5 0.756
MODS score on 1st d of admission 5.1± 1.7 5.5± 1.6 0.389
APACHE II¼Acute Physiology and Chronic Health Evaluation; F¼ female;
GCS¼Glasgow Coma Score; GOS¼Glasgow Outcome Scale; M¼male;
MAP¼mean arterial pressure; MODS¼Multiple Organ Dysfunction Score;
SOFA¼ Sequential Organ Failure Assessment.
Table 5
The relationship between patient characteristic features on admission and
acute kidney injury.
p 95% confidence interval
Sex (M/F) 0.959 0.078e11.294
Age (y) 0.717 0.972e1.043
GCS 0.515 0.796e1.046
SOFA score 0.163 0.823e3.188
MODS score 0.082 0.449e1.050
APACHE score 0.044 1.005e1.410
APACHE¼Acute Physiology and Chronic Health Evaluation; F¼ female;
GCS¼Glasgow Coma Score; M¼male; MODS¼Multiple Organ
Dysfunction Score; SOFA¼ Sequential Organ Failure Assessment.
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APACHE II score were not significantly different between the
patients with and without AKI (Table 3).
Mortality rates (62%) and the proportion of patients who
developed MOF (23.8% based on SOFA and 19% based on
MODS) were significantly higher in patients with AKI
( p¼ 0.002 for mortality rates and p 0.0001 for MOF rates;
Table 4).
Finally, using the multivariable regression analysis, the
only feature shown to be significantly related to AKI was
APACHE II score on admission day ( p¼ 0.044, 95% confi-
dence interval¼ 1.005e1.410; Table 5).
4. Discussion
This descriptive analytic study was performed at a Level I
trauma center to estimate the incidence of AKI among patients
with severe TBI admitted to ICU, and to evaluate the associ-
ation of AKI with risk factors and outcomes. SOFA and MOD
scores were used to detect the MOF, and KDIGO criteria were
used to diagnose AKI during the period of the ICU stay. Based
on KDIGO criteria, the incidence of AKI reported was as high
as 25%. APACHE II score and GOS on admission day were
significantly related to the development of AKI. Mortality rate
was 62% in the cohort with AKI; MOF rate was 23.8% based
on SOFA and 19% based on the MODS system.Table 4
Comparison of multi-organ failure (MOF), poor neurologic outcome, and
mortality rates between patients with and without acute kidney injury (AKI).
AKI No AKI p
n¼ 21 n¼ 62
MOF (SOFA) 23.8% 0% 0.0001
n¼ 5 n¼ 0
MOF (MODS) 19% 0% 0.0001
n¼ 4 n¼ 0
Poor neurologic outcome 95% 92% 0.674
n¼ 20 n¼ 57
Mortality 62% 22.6% 0.002
n¼ 13 n¼ 14
MODS¼Multiple Organ Dysfunction Score; SOFA¼ Sequential Organ
Failure Assessment.Rodling Wahlstrom et al17 reported 0.1% renal dysfunction
in 93 patients with severe TBI and no patients with renal
failure defined by SOFA. Zygun et al18 conducted a study
using MOD score to establish non-neurologic organ failure
among 209 patients with severe TBI. They reported an inci-
dence of 7% renal failure and 0.5% renal dysfunction. None of
the ICU predicting scoring systems, including MODS and
SOFA, are validated for the diagnosis of AKI.18
Although the study population in both trials were patients
with severe TBI, the SOFA and MOD scoring systems have
been applied for the diagnosis of renal dysfunction/failure. We
applied the KDIGO system, which resulted in the diagnosis of
25.3% patients as having AKI.
Moore et al19 reported an incidence of 9.2% among 207
patients with moderate and severe TBI using RIFLE criteria.
Mortality rates were estimated as 42% and 18% in patients
with AKI and with no AKI, respectively. They showed a
significant correlation between age, severity of illness
measured by APACHE III, admittance to hospital, and AKI.
Presenting age and high scores of APACHE III as risk factors
for AKI, was the first trial evaluating the risk factors for AKI
development. We used the latest criteria for diagnosis of AKI
approved by the KDIGO panel in 2012, and we enrolled patients
with TBI of severe type not moderate type, and we reported the
incidence of AKI as high as 25%. Reporting higher rates of
mortality in patients with AKI and without AKI (95% vs. 92%)
could be related to our study population, which was of severe
type TBI only, unlikemoderate and severewhichwas included in
Moore et al's19 study. Another differenceworthmentioning is the
applied system for diagnosing AKI; i.e., applying KDIGO
instead of RIFLE as in this study.
Li et al8 reported an incidence of 23% of AKI among 136
patients with severe TBI; of which 55% died and 74% of cases
resulted in poor neurologic outcome. Compared with patients
with no AKI, patients with AKI showed a poor prognosis and
high rates of mortality. The statistical relationship between
development of AKI and age, admission GCS, level of blood
urea nitrogen, and creatinine on admission was significant.
They used AKIN criteria for the diagnosis of AKI.8
The association of AKI with higher rates of mortality in Li
et al's8 study is similar to our findings but we found no sig-
nificant association between AKI and neurologic outcome. In
our study GOS and APACHE II were the only features related
93S. Ramtinfar et al. / Journal of Acute Medicine 6 (2016) 90e94to AKI. We found no association between age or admission
GCS with AKI. This contradictory finding could be justified
by the discrepancy between study populations in terms of size,
mean age, mean arterial pressure, and other basic character-
istic features on admission.
Postinjury vasoconstriction of kidneys caused by sympa-
thetic overactivity as a response to severe brain damage is a
leading cause of AKI.20 Mannitol used for decreasing the
intracranial pressure and preventing further brain edema and
herniation might result in nephrotoxicity and thus is a risk
factor for developing AKI.21e23 Application of other nephro-
toxic drugs, rhabdomyolysis, and hospital-related complica-
tions like sepsis are all factors that play a role.24
Kidneys could be affected by inflammatory transmitters
released after other organ failures like the lungs and liver.25
AKI could be the initiator of a process ending in MOF or
could be the result of systemic inflammatory transmitters
generated in MOF. AKI, when it takes place, can result in
brain endothelial damage, inflammation, and finally brain
edema and encephalopathy, worsening the patient outcome
and increasing the mortality rate.26e28
As shown in our study, 62% of patients who developed AKI
died and 95% of them showed a poor neurologic outcome.
MOF, defined by SOFA, was reported as high as 23.8%, and
the MODS system revealed 19% as having MOF.
The association of AKI to high rates of mortality, poor
neurologic outcome, and MOF, signifies the role of renopro-
tective measures and early diagnosis in order to prevent any
injury and restore the kidney function.8,19
Patients with severe head trauma are a specific subtype of
ICU patients with high rates of mortality and morbidity. Un-
fortunately, most of them are a young population, therefore,
the burden on the health system is noteworthy. To our
knowledge, few studies provided information about concom-
itant AKI using KDIGO in this subtype of patients. This study
was performed in order to describe the AKI deteriorating the
course and the prognosis of severely head injured patients.
Although there is no definitive therapy for early diagnosed
AKI and the only available choice to date is resuscitative
management, applying renal hygiene guidelines is always
protective. Finding new biomarkers to diagnose the at-risk
population for renal injury or to detect the AKI in earlier
stages will help to save and restore the kidney function. Recent
research is investigating new biomarkers like kidney injury
molecule-1, neutrophil gelatinase-associated lipocalin, liver
fatty-acid binding protein, and interleukin-18 to detect any
decrease in renal function in early stages.29
Erythropoietin has been proposed as a novel treatment in
the setting of brain trauma and a protective therapy for kid-
neys. Neuroprotective and nephroprotective effects have been
shown in multiple rat models, but the exact mechanisms and
the efficacy in human patients is an open field of study.30,31
New biomarkers for earlier diagnosis of AKI along with
effective treatments for AKI with concomitant protective ef-
fect on the brain could change the course and prognosis of
patients with severe TBI and AKI.Conflicts of interest
The authors report no conflicts of interest.
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